Abstract
The associations between CYP1B1 polymorphisms and head and neck squamous cell carcinoma (HNSCC) risk have been conflicting. We therefore performed a meta-analysis to derive a more precise relationship. Six published case-control studies were collected; odds ratios (ORs) with 95% confidence interval (CI) were used to assess the association between CYP1B1 Leu432Val, Asn453Ser polymorphisms, and HNSCC risk. The Sensitivity analysis and publication bias also were performed to guarantee the statistical power. Overall, the pooled OR with 95% CIs indicated that CYP1B1 Leu432Val polymorphism was significantly related with HNSCC risk (for Val vs. Leu: OR = 1.13, 95% CI = 1.03-1.25, P = 0.014, P(heterogeneity) = 0.141; for Val/Val vs. Leu/Leu: OR = 1.30, 95% CI = 1.06-1.60, P = 0.013, P heterogeneity = 0.253; for Val/Val vs. Leu/Leu + Leu/Val: OR = 1.23, 95% CI = 1.05-1.46, P = 0.013, P(heterogeneity) = 0.456). The similar results were also been found in succeeding analysis of HWE and stratified analysis of Caucasian population. Furthermore, no significant association between CYP1B1 Asn453Ser polymorphism and HNSCC risk was found in this meta-analysis. In conclusion, our meta-analysis demonstrates that CYP1B1 Leu432Val polymorphism may b...Continue Reading
References
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Nov 8, 1996·The Journal of Biological Chemistry·Y M TangW F Greenlee
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Nov 14, 1997·Science·F P Perera
Nov 7, 1998·Carcinogenesis·J H KimT R Sutter
Jul 30, 1999·Carcinogenesis·T ShimadaK Inoue
May 2, 2000·JAMA : the Journal of the American Medical Association·D F StroupS B Thacker
Jun 22, 2000·Pharmacogenetics·D N LiT Friedberg
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·G I MurrayM D Burke
May 28, 2003·Journal of Clinical Epidemiology·John AttiaCatherine D'Este
Jan 22, 2004·Journal of the National Cancer Institute·P VineisR Doll
Aug 7, 2004·Carcinogenesis·Jeffrey L PortAndrew J Dannenberg
Sep 18, 2004·Cancer Research·Simon D SpivackLaurence S Kaminsky
Nov 24, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·A J SascoK Straif
Apr 13, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Guojun LiQingyi Wei
May 21, 2005·Carcinogenesis·Xia Wen, Thomas Walle
Apr 15, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mia HashibePaul Brennan
Dec 11, 2007·Mutation Research·Arvind P SinghDevendra Parmar
May 20, 2008·Lancet·Athanassios ArgirisRobert L Ferris
Jun 24, 2008·Journal of Toxicology and Environmental Health. Part a·Volker HarthKatja Ickstadt
Jul 7, 2009·Oral Oncology·Angela C ChiDavid T Kurtz
Dec 8, 2009·Cancer Genetics and Cytogenetics·Jun TaiDemin Han
Jun 24, 2010·Neoplasma·P SoucekL Vodickova
Jan 6, 2011·Cancer Prevention Research·Ekaterina G ShatalovaMargie L Clapper
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
May 10, 2011·Oral Oncology·Antonia KolokythasGuy R Adami
Nov 25, 2011·PloS One·Shalmali PradhanArun Kumar
Citations
Aug 4, 2015·Nature Genetics·Matthew H LawMark M Iles
Nov 30, 2016·Human Genomics·Lucia F Jorge-NebertDaniel W Nebert
Mar 6, 2016·Medicine·Xianlu ZhuoXueyuan Zhang
Sep 25, 2021·Scientific Reports·Daniela PresaKlaus Pors